Clinical Trials Browser

Phase 2 × Recruiting × Axitinib × Clear all

NCT07469683 2026-03-13

An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Phase 2 Recruiting

Carcinoma, Renal Cell, Neoplasms

NCT03297606 2026-03-04

CAPTUR

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT05327686 2026-01-14

SAMURAI

Phase 2 Recruiting

Carcinoma, Renal Cell

NCT04996823 2025-12-04

Axitinib + Ipilimumab in Advanced Melanoma

Phase 2 Recruiting

Melanoma, Skin Neoplasms

NCT06962787 2025-11-17

A Study of BL-B01D1+TKI±Pembrolizumab in Patients With Locally Advanced or Metastatic Renal Cancer

Phase 2 Recruiting

Kidney Neoplasms

NCT07172386 2025-09-16

Preoperative Therapy of Super-selective Tumor Artery Embolization Combined With Toripalimab and Axitinib in Advanced RCC

Phase 2 Recruiting

Carcinoma, Renal Cell

NCT04341181 2025-07-25

ProTarget

Phase 2 Recruiting

Neoplasms

NCT05969496 2025-04-04

NEOPAX

Phase 2 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT06889649 2025-03-21

SABR Combined with Axitinib and Toripalimab in Recurrent or Metastatic RCC

Phase 2 Recruiting

Radiation Therapy

NCT06211114 2024-11-26

Study to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct Carcinoma

Phase 2 Recruiting

Carcinoma, Renal Cell

NCT05420220 2024-05-01

Study of KN046 in Subjects With Advanced Non-Small Cell Lung Cancer

Phase 2 Recruiting

Advanced Non-small Cell Lung Cancer

NCT05817903 2023-05-08

AxIn

Phase 2 Recruiting

Carcinoma, Renal Cell